High prevalence of classic cardiovascular risk factors in a population of university students from South Central Chile;Alta prevalencia de factores de riesgo cardiovascular clásicos en una población de estudiantes universitarios de la región centro-sur de Chile

Revista Espanola de Cardiologia

Volumn 59, Issue 11, 2006, Pages 1099-1105

  Palomo, Iván F ^a   Torres, Gaby I ^a   Alarcón, Marcelo A ^a   Maragaño, Patricio J ^b   Leiva, Elba ^a   Mujica, Verónica ^b  

^a UNIVERSIDAD DE TALCA   (Chile)

^b HOSPITAL REGIONAL DE TALCA   (Chile)

Author keywords

Blood pressure; Cardiovascular risk factors; Cholesterol; Glycemia; Metabolic syndrome; Waist diameter

Indexed keywords

GLUCOSE; LIPID;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; RISK REDUCTION; SMOKING; UNIVERSITY STUDENT; WAIST CIRCUMFERENCE;

EID: 33846414396     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095778     Document Type: Article

References (43)

1. World Health Organization. Informe sobre la salud en el mundo. Technical Report Series ISBN 92 4 356207 X. Geneve: WHO; 2002.
2. Berrios X. Time trends in risk factors for chronic diseases: is a new epidemic coming? Rev Med Chil. 1997;125:1405-7.
3. Bustos P, Amigo H, Arteaga A, Acosta AM, Rona RJ. Risk factors of cardiovascular disease among young adults. Rev Med Chil. 2003;131:973-80.
4. 9 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151-83.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
6. Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1996;16:1509-15.
7. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Q. 1988;41:115-40.
8. Puig T, Marti B, Rickenbach M, Dai SF, Casacuberta C, Wietlisbach V, et al. Some determinants of body weight, subcutaneous fat, and fat distribution in 25-64 year old Swiss urban men and woman. Soz Praventivmed. 1990;35:193-200.
9. Heidelberg S-VB. Protocol and Guidelines for Monitoring and Evaluation Procedures. En: Nussel E, editor. CINDI, Countrywide Integrated Noncommunicables Diseases Intervention Programme. Heidelberg: Springer-Verlag; 1987.
10. Habitch J. Estandarización de métodos epidemiológicos cuantitativos sobre el terreno. Bol of Sanit Panam. 1974;76:375-84.
11. Ministerio de Salud, Programa de Salud del Adulto. Manual: Exámen de salud preventivo del adulto. Norma General Técnica No. 9. Santiago de Chile: MINSAL; 1995.
12. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Gudelines Subcommittee. J Hypertens. 1999;17:151-83.
13. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatmen of high blood pressure. Arch Intern Med. 1997;157:2401-2.
14. Vega J, Jadue L, Escobar MC, Jalil J, Espejo F, Delgado I, et al. Prevalence of hypertension in Valparaiso. Results of the base survey of the CARMEN project (Set of measures for the multifactorial reduction of non-transmissible diseases). Rev Med Chil. 1999;127:729-38.
15. Franco V, Oparil S, Carretero OA. Hypertensive therapy: Part II. Circulation. 2004;109:3081-8.
16. Hense HW, Koivisto AM, Kuulasmaa K, Zaborskis A, Kupsc W, Tuomilehto J. Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA project. J Hum Hypertens. 1995;9:935-46.
17. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21:1273-81.
18. US Department of Health and Human Services. Public Health Service. National Institutes of Health. The Sixth Report of The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. NIH Publication. 1997;98:4080.
19. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-23.
20. Lanas F, Del Solar J, Maldonado M, Guerrero MA, Espinoza F. Prevalence of risk factors to cardiovascular disease in group of Chilean employees. Rev Med Chil. 2003;131:129-34.
21. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med. 2004;21:383-7.
22. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39.
23. Masia R, Sala J, Rohlfs I, Piulats R, Manresa J, Marrugat J, et al. Prevalence of diabetes mellitus in the province of Girona, Spain: the REGICOR study. Rev Esp Cardiol. 2004;57:261-4.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
25. US Department of Health and Human Services. Public Health Service. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in adults. NIH Publication. 1998;98:4083.
26. WHO. Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneve: WHO; 1997. p. 3-5.
27. Berrios X, Jadue L, Zenteno J, Ross MI, Rodriguez H. Prevalence of risk factors for chronic diseases. A study in the general population of the metropolitan area, 1986-1987. Rev Med Chil. 1990; 118:597-604.
28. Taussig LM, Kattwinkel J, Friedewald WT, Di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr. 1973;82:380-90.
29. Persu A, De Plaen JF. Recent insights in the development of organ damage caused by hypertension. Acta Cardiol. 2004;59:369-81.
30. Ministerio de Salud de Chile. Encuesta Nacional de Salud 2003. Departamento de Salud Pública de la Pontificia Universidad Católica de Chile. Informe Técnico; 2003
31. Chiang-Salgado M, Casanueva-Escobar V, Cid-Cea X, González-Rubilar U, Olate-Mellado P, Nickel-Paredes F, et al. Factores de riesgo cardiovascular en estudiantes universitarios chilenos. Salud Pública de Mexico. 1999;6:444-51.
32. Fasce E, Pérez H, Boggiano G, Ibanez P, Nieto C. Hypertension in rural communities. Study in the VIII Region, Chile. Rev Med Chil. 1993;121:1058-67.
33. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health. 1998;52:707-15.
34. Rigo Carratala F, Frontera Juan G, Llobera Canaves J, Rodríguez Ruiz T, Borras Bosch I, Fuentespina Vidal E. Prevalencia de factores de riesgo cardiovascular en las isalas Baleares (estudio CORSAIB). Rev Esp Cardiol. 2005;58:1411-9.
35. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-8.
36. Han TS, Van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401-5.
37. Medrano MJ, Cerrato E, Boix R, Delgado-Rodriguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med Clin (Barc). 2005; 124:606-12.
38. Alegría E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, et al. Prevalencia del Síndrome metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol. 2005; 58:797-806.
39. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
40. Baechler R, Mujica V, Aqueveque X, Ramos L, Soto A. Prevalence of diabetes mellitus in the Seventh Region of Chile. Rev Med Chil. 2002;130:1257-64.
41. Jadue L, Vega J, Escobar MC, Delgado I, Garrido C, Lastra P, et al. Risk factors for non communicable diseases: methods and global results of the CARMEN program basal survey. Rev Med Chil. 1999;127:1004-13.
42. Menezes AM, Horta BL, Oliveira AL, Kaufmann RA, Duquia R, Diniz A, et al. Attributed risk to smoking for lung cancer, laryngeal cancer and esophageal cancer. Rev Saude Publica. 2002; 36:129-34.
43. World Health Organization. Tobacco or Health: a global status repor. Technical Report Series. Geneve: WHO; 1997.